BD
Medical devices and connected systems spanning everyday care, drug delivery, monitoring, and intervention.
$189.00
After-hours close−0.52 (−0.27%)
At close$189.52(+0.74%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 122.42%Insiders 0.20%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 275.54M · Float 274.94M · 99.8% free float
Institutions13F, as of Jun 30, 2026
1,461 holders · 337.30M shares · 140 new positions · 687 increased · 547 reduced · 181 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 24.59M | 8.93% | −1.56M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 17.99M | 6.53% | −502.8K | Aug 13, 2026 |
| State Street Corp | 15.00M | 5.44% | +1.18M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 14.97M | 5.43% | −343.1K | Aug 13, 2026 |
| First Eagle Investment Management, LLC | 13.82M | 5.01% | +1.89M | Aug 24, 2026 |
| Invesco Ltd. | 8.90M | 3.23% | −1.28M | Aug 14, 2026 |
| Massachusetts Financial Services Co /MA/ | 8.65M | 3.14% | −450.5K | Aug 3, 2026 |
| Geode Capital Management, LLC | 8.14M | 2.95% | +1.03M | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 21.40M | 13G | Apr 29, 2026 ↗ |
| Vanguard Portfolio Management | 5.40% | 15.39M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Thomas E. Jr Polen | director, officer: Chairman, CEO and President | 110.2K | 0.04% | Aug 14, 2026 |
| Timothy M. Ring | director | 75.3K | 0.03% | Jan 29, 2026 |
| Bilal Muhsin | officer: EVP & President Connected Care | 41.4K | 0.02% | Jul 6, 2026 |
| Bertram L. Scott | director | 36.8K | 0.01% | Feb 18, 2026 |
| Christopher Ian Montague Jones | director | 30.9K | 0.01% | Jan 29, 2026 |
| Christopher DelOrefice | officer: EVP & Chief Financial Officer | 29.2K | 0.01% | Dec 1, 2025 |
| Claire Fraser | director | 28.3K | 0.01% | Sep 11, 2025 |
| Shana Carol Neal | officer: EVP and Chief People Officer | 24.0K | 0.01% | Apr 6, 2026 |
| Michael Feld | officer: EVP, Chief Revenue Officer | 19.7K | 0.01% | Aug 27, 2026 |
| Richard Byrd | officer: EVP & President Interventional | 16.8K | 0.01% | Dec 1, 2025 |
1 ten-percent owner holds 1.3K shares by Form 4, outside the officers-and-directors figure above · 52 people have not refiled in the last 18 months (1.64M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 165 | $188.49 | 19,720 |
| Aug 13, 2026 | Thomas E. Jr Polendirector, officer: Chairman, CEO and President | Sale | 4,152 | $185.00 | 110,163 |
| Aug 11, 2026 | Roland Goetteofficer: EVP and President, EMEA | Sale | 2,438 | $180.84 | 14,856 |
| Jul 27, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $157.13 | 20,934 |
| Jun 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $152.80 | 21,009 |
| Jun 24, 2026 | Michael David Garrisonofficer: EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $145.66 | 13,172 |
| Jun 10, 2026 | Michael David Garrisonofficer: EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $151.48 | 14,272 |
| Jun 1, 2026 | Thomas E. Jr Polendirector, officer: Chairman, CEO and President | Sale | 2,764 | $146.35 | 110,163 |
| May 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $147.35 | 21,084 |
| Apr 27, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 74 | $151.94 | 21,159 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | May 21, 2026 | Jun 19, 2026 ↗ |